Invesco’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.67M | Sell |
669,874
-195,607
| -23% | -$1.75M | ﹤0.01% | 2058 |
|
|
2025
Q4 | $7.32M | Buy |
865,481
+504,291
| +140% | +$3.6M | ﹤0.01% | 2044 |
|
|
2025
Q3 | $1.89M | Buy |
361,190
+87,807
| +32% | +$335K | ﹤0.01% | 2634 |
|
|
2025
Q2 | $946K | Buy |
273,383
+88,552
| +48% | +$263K | ﹤0.01% | 2865 |
|
|
2025
Q1 | $484K | Buy |
184,831
+65,414
| +55% | +$256K | ﹤0.01% | 3161 |
|
|
2024
Q4 | $492K | Buy |
119,417
+5,261
| +5% | +$28.6K | ﹤0.01% | 3242 |
|
|
2024
Q3 | $808K | Sell |
114,156
-357
| -0.3% | -$2.67K | ﹤0.01% | 3005 |
|
|
2024
Q2 | $747K | Sell |
114,513
-2,370
| -2% | -$16.2K | ﹤0.01% | 3091 |
|
|
2024
Q1 | $970K | Sell |
116,883
-30,198
| -21% | -$295K | ﹤0.01% | 3007 |
|
|
2023
Q4 | $1.62M | Sell |
147,081
-6,227
| -4% | -$52.5K | ﹤0.01% | 2694 |
|
|
2023
Q3 | $1.29M | Buy |
153,308
+26,424
| +21% | +$284K | ﹤0.01% | 2753 |
|
|
2023
Q2 | $1.59M | Buy |
126,884
+52,931
| +72% | +$658K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $1.22M | Buy |
73,953
+15,085
| +26% | +$270K | ﹤0.01% | 2830 |
|
|
2022
Q4 | $879K | Buy |
58,868
+1,061
| +2% | +$20.3K | ﹤0.01% | 2991 |
|
|
2022
Q3 | $1.29M | Buy |
57,807
+188
| +0.3% | +$4.13K | ﹤0.01% | 2830 |
|
|
2022
Q2 | $966K | Buy |
57,619
+4,293
| +8% | +$92K | ﹤0.01% | 3006 |
|
|
2022
Q1 | $1.6M | Buy |
53,326
+23,491
| +79% | +$570K | ﹤0.01% | 2873 |
|
|
2021
Q4 | $917K | Buy |
29,835
+2,440
| +9% | +$77.1K | ﹤0.01% | 3111 |
|
|
2021
Q3 | $864K | Buy |
27,395
+4,118
| +18% | +$139K | ﹤0.01% | 3174 |
|
|
2021
Q2 | $852K | Buy |
23,277
+13,725
| +144% | +$452K | ﹤0.01% | 3193 |
|
|
2021
Q1 | $330K | Buy |
9,552
+2,548
| +36% | +$111K | ﹤0.01% | 3515 |
|
|
2020
Q4 | $291K | Buy |
+7,004
| New | +$317K | ﹤0.01% | 3431 |
|
Other funds holding RLAY
SIAU
CC
CC
PA
BG
VCM
NI
TCM